nanoarrays | GenomeWeb


QuantuMDx will use Scienion's ultra-low-volume liquid handling technologies in its Q-Poc handheld molecular diagnostic device.

The team showed the approach could successfully monitor cytokines in infants after heart surgery, and is involved now in a larger clinical study expanding this research. 

Cambridge Bioscience will be NanoInk's exclusive distributor in the UK and Ireland, NanoInk said this week.

NanoInk has tapped two distributors to sell its nanofabrication platforms in the Asia Pacific region.

New Product Watch


Avantra Biosciences' Rapid Assay Prototyping Service, NanoInk's NanoArray Assay System

Roughly 40 percent of the funding will go toward NanoInk's BioDiscovery division, where it will be used to build out the company's sales and marketing organization and fund development of new products based on its protein nanoarray platform.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.